361 related articles for article (PubMed ID: 18824382)
1. Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade?
Bragd J; Adamson U; Bäcklund LB; Lins PE; Moberg E; Oskarsson P
Diabetes Metab; 2008 Dec; 34(6 Pt 1):612-6. PubMed ID: 18824382
[TBL] [Abstract][Full Text] [Related]
2. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Moram CBM; Salles GF
Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients.
Teliti M; Cogni G; Sacchi L; Dagliati A; Marini S; Tibollo V; De Cata P; Bellazzi R; Chiovato L
Diab Vasc Dis Res; 2018 Sep; 15(5):424-432. PubMed ID: 29911415
[TBL] [Abstract][Full Text] [Related]
4. Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes.
Yang CY; Su PF; Hung JY; Ou HT; Kuo S
Cardiovasc Diabetol; 2020 Jul; 19(1):105. PubMed ID: 32631323
[TBL] [Abstract][Full Text] [Related]
5. Glycaemic control and microvascular complications in a large cohort of Italian Type 1 diabetic out-patients.
Lepore G; Bruttomesso D; Nosari I; Tiengo A; Trevisan R
Diabetes Nutr Metab; 2002 Aug; 15(4):232-9. PubMed ID: 12416660
[TBL] [Abstract][Full Text] [Related]
6. Does severe hypoglycaemia influence microvascular complications in Type 1 diabetes? An analysis of the Diabetes Control and Complications Trial database.
Kilpatrick ES; Rigby AS; Atkin SL; Frier BM
Diabet Med; 2012 Sep; 29(9):1195-8. PubMed ID: 22332940
[TBL] [Abstract][Full Text] [Related]
7. Pattern of long-term complications in Sudanese insulin-treated diabetic patients.
Elbagir MN; Eltom MA; Mahadi EO; Berne C
Diabetes Res Clin Pract; 1995 Oct; 30(1):59-67. PubMed ID: 8745207
[TBL] [Abstract][Full Text] [Related]
8. The relevance of persistent C-peptide secretion in type 1 (insulin-dependent) diabetes mellitus to glycaemic control and diabetic complications.
Winocour PH; Jeacock J; Kalsi P; Gordon C; Anderson DC
Diabetes Res Clin Pract; 1990 Apr; 9(1):23-35. PubMed ID: 2351037
[TBL] [Abstract][Full Text] [Related]
9. Occurrence and interrelationships of complications in insulin-dependent diabetes in Finland.
Ebeling P; Koivisto VA
Acta Diabetol; 1997 Mar; 34(1):33-8. PubMed ID: 9134055
[TBL] [Abstract][Full Text] [Related]
10. Diabetes mellitus in Egypt: glycaemic control and microvascular and neuropathic complications.
Herman WH; Aubert RE; Engelgau MM; Thompson TJ; Ali MA; Sous ES; Hegazy M; Badran A; Kenny SJ; Gunter EW; Malarcher AM; Brechner RJ; Wetterhall SF; DeStefano F; Smith PJ; Habib M; abd el Shakour S; Ibrahim AS; el Behairy EM
Diabet Med; 1998 Dec; 15(12):1045-51. PubMed ID: 9868980
[TBL] [Abstract][Full Text] [Related]
11. Good glycemic control remains crucial in prevention of late diabetic complications--the Linköping Diabetes Complications Study.
Nordwall M; Arnqvist HJ; Bojestig M; Ludvigsson J
Pediatr Diabetes; 2009 May; 10(3):168-76. PubMed ID: 19175900
[TBL] [Abstract][Full Text] [Related]
12. Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC).
Prince CT; Becker DJ; Costacou T; Miller RG; Orchard TJ
Diabetologia; 2007 Nov; 50(11):2280-8. PubMed ID: 17768606
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the relationships of the glucose tolerance test and the glycated haemoglobin assay with diabetic vascular disease in the community. The Islington Diabetes Survey.
Jackson CA; Yudkin JS; Forrest RD
Diabetes Res Clin Pract; 1992 Aug; 17(2):111-23. PubMed ID: 1425145
[TBL] [Abstract][Full Text] [Related]
14. Sex differences in the association of prediabetes and type 2 diabetes with microvascular complications and function: The Maastricht Study.
de Ritter R; Sep SJS; van der Kallen CJH; van Greevenbroek MMJ; de Jong M; Vos RC; Bots ML; Reulen JPH; Houben AJHM; Webers CAB; Berendschot TTJM; Dagnelie PC; Eussen SJPM; Schram MT; Koster A; Peters SAE; Stehouwer CDA
Cardiovasc Diabetol; 2021 May; 20(1):102. PubMed ID: 33962619
[TBL] [Abstract][Full Text] [Related]
15. Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes.
Cavalot F
Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():3-8. PubMed ID: 24034513
[TBL] [Abstract][Full Text] [Related]
16. Limited joint mobility is associated with the presence but does not predict the development of microvascular complications in type 1 diabetes.
Arkkila PE; Kantola IM; Viikari JS; Rönnemaa T; Vähätalo MA
Diabet Med; 1996 Sep; 13(9):828-33. PubMed ID: 8891458
[TBL] [Abstract][Full Text] [Related]
17. Development of Microvascular Complications and Effect of Concurrent Risk Factors in Type 1 Diabetes: A Multistate Model From an Observational Clinical Cohort Study.
Bjerg L; Hulman A; Carstensen B; Charles M; Jørgensen ME; Witte DR
Diabetes Care; 2018 Nov; 41(11):2297-2305. PubMed ID: 30131399
[TBL] [Abstract][Full Text] [Related]
18. The rise and fall of HbA(1c) as a risk marker for diabetes complications.
Kilpatrick ES
Diabetologia; 2012 Aug; 55(8):2089-91. PubMed ID: 22711013
[TBL] [Abstract][Full Text] [Related]
19. Persistent C-peptide levels and microvascular complications in childhood onset type 1 diabetes of long duration.
Williams KV; Becker DJ; Orchard TJ; Costacou T
J Diabetes Complications; 2019 Sep; 33(9):657-661. PubMed ID: 31239235
[TBL] [Abstract][Full Text] [Related]
20. [Blood glucose self-monitoring in intensified insulin therapy: acceptance of frequent measurements and effect on quality of diabetic control].
Weitgasser R; Schnöll F; Pretsch I; Gruber U; Sailer S
Acta Med Austriaca; 1998; 25(2):61-4. PubMed ID: 9681045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
